Dafna Bar-Sagi - Publications

Affiliations: 
Basic Medical Science New York University, New York, NY, United States 
Area:
Oncology, Molecular Biology, Biochemistry

145 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Yoo DY, Hauser AD, Joy ST, Bar-Sagi D, Arora PS. Covalent Targeting of Ras G12C by Rationally Designed Peptidomimetics. Acs Chemical Biology. PMID 32378881 DOI: 10.1021/Acschembio.0C00204  0.406
2020 Parker SJ, Amendola CR, Hollinshead KER, Yu Q, Yamamoto K, Encarnacion-Rosado J, Rose RE, LaRue MM, Sohn ASW, Biancur DE, Paulo JA, Gygi SP, Jones DR, Wang H, Philips MR, ... Bar-Sagi D, et al. Selective alanine transporter utilization creates a targetable metabolic niche in pancreatic cancer. Cancer Discovery. PMID 32341021 DOI: 10.1158/2159-8290.Cd-19-0959  0.316
2020 Das S, Shapiro B, Vucic EA, Vogt S, Bar-Sagi D. Tumor Cell-Derived IL-1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer. Cancer Research. PMID 31915130 DOI: 10.1158/0008-5472.Can-19-2080  0.337
2020 LaRue MM, Cullis J, Bar-Sagi D. Abstract PR22: Collagen scavenging alters macrophage phenotype in pancreatic cancer Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-Pr22  0.329
2019 Ramirez C, Hauser AD, Vucic EA, Bar-Sagi D. Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis. Nature. 576: 477-481. PMID 31827278 DOI: 10.1038/S41586-019-1831-X  0.46
2019 Wang L, Yang H, Zamperone A, Diolaiti D, Palmbos PL, Abel EV, Purohit V, Dolgalev I, Rhim AD, Ljungman M, Hadju CH, Halbrook CJ, Bar-Sagi D, di Magliano MP, Crawford HC, et al. ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis. Genes & Development. PMID 31048544 DOI: 10.1101/Gad.323303.118  0.326
2019 Das S, Bar-Sagi D. BTK signaling drives CD1dCD5 regulatory B-cell differentiation to promote pancreatic carcinogenesis. Oncogene. PMID 30635655 DOI: 10.1038/S41388-018-0668-3  0.344
2019 Siolas D, Vucic E, Cullis J, Choi M, Bar-Sagi D. Abstract 2797: Accumulation of neutrophils in the tumor microenvironment promotes resistance to immunotherapy in pancreatic cancer Cancer Research. 79: 2797-2797. DOI: 10.1158/1538-7445.Am2019-2797  0.324
2018 Aiello NM, Maddipati R, Norgard RJ, Balli D, Li J, Yuan S, Yamazoe T, Black T, Sahmoud A, Furth EE, Bar-Sagi D, Stanger BZ. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. Developmental Cell. 45: 681-695.e4. PMID 29920274 DOI: 10.1016/J.Devcel.2018.05.027  0.316
2017 Cullis J, Das S, Bar-Sagi D. Kras and Tumor Immunity: Friend or Foe? Cold Spring Harbor Perspectives in Medicine. PMID 29229670 DOI: 10.1101/Cshperspect.A031849  0.317
2017 Jang JE, Hajdu CH, Liot C, Miller G, Dustin ML, Bar-Sagi D. Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer. Cell Reports. 20: 558-571. PMID 28723561 DOI: 10.1016/J.Celrep.2017.06.062  0.347
2017 Fehrenbacher N, Tojal da Silva I, Ramirez C, Zhou Y, Cho KJ, Kuchay S, Shi J, Thomas S, Pagano M, Hancock JF, Bar-Sagi D, Philips MR. The G protein-coupled receptor GPR31 promotes membrane association of KRAS. The Journal of Cell Biology. PMID 28619714 DOI: 10.1083/Jcb.201609096  0.325
2017 Cohen DJ, Grabocka E, Bar-Sagi D, Godin R, Leichman LP. A phase Ib study combining irinotecan with AZD1775, a selective WEE 1 kinase inhibitor, in RAS/RAF mutated metastatic colorectal cancer patients who progressed on first line therapy. Journal of Clinical Oncology. 35: TPS3627-TPS3627. DOI: 10.1200/Jco.2017.35.15_Suppl.Tps3627  0.352
2016 Sundstrom A, Bar-Sagi D, Mishra B. Simulating Heterogeneous Tumor Cell Populations. Plos One. 11: e0168984. PMID 28030620 DOI: 10.1371/Journal.Pone.0168984  0.712
2016 Davidson SM, Jonas O, Keibler MA, Hou HW, Luengo A, Mayers JR, Wyckoff J, Del Rosario AM, Whitman M, Chin CR, Condon KJ, Lammers A, Kellersberger KA, Stall BK, Stephanopoulos G, ... Bar-Sagi D, et al. Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors. Nature Medicine. PMID 28024083 DOI: 10.1038/Nm.4256  0.346
2016 Grabocka E, Bar-Sagi D. Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules. Cell. 167: 1803-1813.e12. PMID 27984728 DOI: 10.1016/J.Cell.2016.11.035  0.333
2016 Daley D, Zambirinis CP, Seifert L, Akkad N, Mohan N, Werba G, Barilla R, Torres-Hernandez A, Hundeyin M, Mani VR, Avanzi A, Tippens D, Narayanan R, Jang JE, Newman E, ... ... Bar-Sagi D, et al. γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation. Cell. PMID 27569912 DOI: 10.1016/J.Cell.2016.07.046  0.359
2016 Christensen SM, Tu HL, Jun JE, Alvarez S, Triplet MG, Iwig JS, Yadav KK, Bar-Sagi D, Roose JP, Groves JT. One-way membrane trafficking of SOS in receptor-triggered Ras activation. Nature Structural & Molecular Biology. PMID 27501536 DOI: 10.1038/Nsmb.3275  0.632
2016 Sundstrom A, Grabocka E, Bar-Sagi D, Mishra B. Histological Image Processing Features Induce a Quantitative Characterization of Chronic Tumor Hypoxia. Plos One. 11: e0153623. PMID 27093539 DOI: 10.1371/Journal.Pone.0153623  0.702
2016 Jang J, Hajdu CH, Miller G, Dustin ML, Bar-Sagi D. Abstract A100: Crosstalk between regulatory T cells and tumor-associated dendritic cells controls antitumor immunity in pancreatic cancer Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-A100  0.347
2016 Bar-Sagi D. Abstract IA21: Ras oncogene in cancer pathogenesis and therapy Cancer Research. 76. DOI: 10.1158/1538-7445.Fbcr15-Ia21  0.465
2016 Cullis JE, Taylor L, Low S, Bar-Sagi D. Abstract 3001: Accurins are endocytosed by KRAS-mutant cells via macropinocytosis Cancer Research. 76: 3001-3001. DOI: 10.1158/1538-7445.Am2016-3001  0.384
2015 Fennell M, Commisso C, Ramirez C, Garippa R, Bar-Sagi D. High-content, full genome siRNA screen for regulators of oncogenic HRAS-driven macropinocytosis. Assay and Drug Development Technologies. 13: 347-55. PMID 26267765 DOI: 10.1089/Adt.2015.660  0.427
2015 Grabocka E, Commisso C, Bar-Sagi D. Molecular pathways: targeting the dependence of mutant RAS cancers on the DNA damage response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1243-7. PMID 25424849 DOI: 10.1158/1078-0432.Ccr-14-0650  0.453
2015 Siolas D, Aristizabal O, Byrne K, Leichman LP, Vonderheide RH, Bar-Sagi D. Preclinical immunotherapy studies using an orthotopic pancreatic cancer mouse model. Journal of Clinical Oncology. 33: 324-324. DOI: 10.1200/Jco.2015.33.3_Suppl.324  0.322
2015 Grabocka E, Choi M, Cohen DJ, Godin R, Leichman LP, Bar-Sagi D. Selective sensitization of Ras-mutant (Ras-m) cancer cells to DNA-damaging chemotherapy by Wee1 inhibition with AZD1775. Journal of Clinical Oncology. 33: e13517-e13517. DOI: 10.1200/Jco.2015.33.15_Suppl.E13517  0.425
2015 Commisso C, Ramirez C, Soydaner-Azeloglu R, Bajor DL, Vonderheide RH, Bar-Sagi D. Abstract PR08: Pulling out all the stops: Exploiting macropinocytosis inhibition for the treatment of pancreatic cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-Pr08  0.428
2015 Pylayeva-Gupta Y, Handler JS, Hajdu C, Bar-Sagi D. Abstract B62: The role of B regulatory cells in pancreatic cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B62  0.31
2015 Handler J, Bar-Sagi D. Abstract A12: Establishing in vitro and in vivo models of pancreatic ductal adenocarcinoma (PDA) utilizing both acinar and ductal lineages Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A12  0.329
2015 Cullis JE, Siolas D, Maitra A, Bar-Sagi D. Abstract LB-224: Nab-paclitaxel and agonist CD40 mAb combination therapy induces tumor-associated macrophage polarization switching in pancreatic cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-224  0.314
2014 Lubkov V, Bar-Sagi D. E-cadherin-mediated cell coupling is required for apoptotic cell extrusion. Current Biology : Cb. 24: 868-74. PMID 24704076 DOI: 10.1016/J.Cub.2014.02.057  0.762
2014 Grabocka E, Pylayeva-Gupta Y, Jones MJ, Lubkov V, Yemanaberhan E, Taylor L, Jeng HH, Bar-Sagi D. Wild-type H- and N-Ras promote mutant K-Ras-driven tumorigenesis by modulating the DNA damage response. Cancer Cell. 25: 243-56. PMID 24525237 DOI: 10.1016/J.Ccr.2014.01.005  0.793
2014 Commisso C, Flinn RJ, Bar-Sagi D. Determining the macropinocytic index of cells through a quantitative image-based assay. Nature Protocols. 9: 182-92. PMID 24385148 DOI: 10.1038/Nprot.2014.004  0.366
2014 Nickerson S, Joy ST, Arora PS, Bar-Sagi D. Abstract B46: Stabilized helices targeting the RAS-SOS interaction as inhibitors of RAS-dependent cancer cell growth Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-B46  0.489
2014 Court H, Philips MR, Bar-Sagi D. The biology of K-Ras signaling pathways in pancreatic cancer Molecular Genetics of Pancreatic Cancer. 83-115. DOI: 10.1007/978-1-4614-6549-2_5  0.358
2013 Nickerson S, Joy ST, Arora PS, Bar-Sagi D. An orthosteric inhibitor of the RAS-SOS interaction. The Enzymes. 34: 25-39. PMID 25034099 DOI: 10.1016/B978-0-12-420146-0.00002-0  0.483
2013 Court H, Amoyel M, Hackman M, Lee KE, Xu R, Miller G, Bar-Sagi D, Bach EA, Bergö MO, Philips MR. Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression. The Journal of Clinical Investigation. 123: 4681-94. PMID 24216479 DOI: 10.1172/Jci65764  0.462
2013 Dultz LA, Dhar S, Ogilvie JB, Heller KS, Bar-Sagi D, Patel KN. Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer. Surgery. 154: 1239-44; discussion . PMID 24094449 DOI: 10.1016/J.Surg.2013.06.024  0.311
2013 Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ, Hackett S, Grabocka E, Nofal M, Drebin JA, Thompson CB, Rabinowitz JD, Metallo CM, Vander Heiden MG, Bar-Sagi D. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature. 497: 633-7. PMID 23665962 DOI: 10.1038/Nature12138  0.453
2013 Commisso C, Chenna V, Grabocka E, Ramirez C, Anirban M, Bar-Sagi D. Abstract PR12: Bringing the outside in: Macropinocytosis and cancer therapeutics Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Pr12  0.487
2013 Grabocka E, Pylayeva-Gupta Y, Yemanaberhan E, Lubkov V, Taylor L, Bar-Sagi D. Abstract PR03: Selective sensitization of mutant K-Ras cancer cells to DNA damage based therapies by targeting wild type H- and N-Ras. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-Pr03  0.804
2012 Jeng HH, Taylor LJ, Bar-Sagi D. Sos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis Nature Communications. 3. PMID 23132018 DOI: 10.1038/Ncomms2173  0.727
2012 Zheng ZY, Xu L, Bar-Sagi D, Chang EC. Escorting Ras. Small Gtpases. 3: 236-9. PMID 22735486 DOI: 10.4161/sgtp.20460  0.357
2012 Yang MH, Nickerson S, Kim ET, Liot C, Laurent G, Spang R, Philips MR, Shan Y, Shaw DE, Bar-Sagi D, Haigis MC, Haigis KM. Regulation of RAS oncogenicity by acetylation. Proceedings of the National Academy of Sciences of the United States of America. 109: 10843-8. PMID 22711838 DOI: 10.1073/Pnas.1201487109  0.487
2012 Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell. 21: 836-47. PMID 22698407 DOI: 10.1016/J.Ccr.2012.04.024  0.335
2012 Cao Y, E G, Wang E, Pal K, Dutta SK, Bar-Sagi D, Mukhopadhyay D. VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression. Cancer Research. 72: 3912-8. PMID 22693250 DOI: 10.1158/0008-5472.Can-11-4058  0.38
2012 Zheng ZY, Cheng CM, Fu XR, Chen LY, Xu L, Terrillon S, Wong ST, Bar-Sagi D, Songyang Z, Chang EC. CHMP6 and VPS4A mediate the recycling of Ras to the plasma membrane to promote growth factor signaling. Oncogene. 31: 4630-8. PMID 22231449 DOI: 10.1038/Onc.2011.607  0.473
2012 Ahearn IM, Haigis K, Bar-Sagi D, Philips MR. Regulating the regulator: post-translational modification of RAS. Nature Reviews. Molecular Cell Biology. 13: 39-51. PMID 22189424 DOI: 10.1038/Nrm3255  0.467
2012 Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Metallo CM, Heiden MGV, Bar-Sagi D. Abstract PR5: Macropinocytosis as a mechanism of amino acid supply. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-Pr5  0.474
2012 Pylayeva-Gupta Y, Lee KE, Miller G, Bar-Sagi D. Abstract A66: KRas-mediated modulation of the immune response in pancreatic neoplasia. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A66  0.311
2012 Commisso C, Soydaner-Azeloglu RG, Bar-Sagi D. Abstract 5147: Glutamine addiction: Recognizing and harnessing the pathometabolic potential of Ras-mediated macropinocytosis Cancer Research. 72: 5147-5147. DOI: 10.1158/1538-7445.Am2012-5147  0.44
2011 Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D. RAS oncogenes: weaving a tumorigenic web. Nature Reviews. Cancer. 11: 761-74. PMID 21993244 DOI: 10.1038/Nrc3106  0.478
2011 Patgiri A, Yadav KK, Arora PS, Bar-Sagi D. An orthosteric inhibitor of the Ras-Sos interaction. Nature Chemical Biology. 7: 585-7. PMID 21765406 DOI: 10.1038/Nchembio.612  0.648
2010 Nimnual AS, Taylor LJ, Nyako M, Jeng HH, Bar-Sagi D. Perturbation of cytoskeleton dynamics by the opposing effects of Rac1 and Rac1b. Small Gtpases. 1: 89-97. PMID 21686260 DOI: 10.4161/Sgtp.1.2.14427  0.684
2010 Xu L, Zhou JL, Cohen M, Bar-Sagi D, Patel KN. Spry2 expression correlates with BRAF mutation in thyroid cancer. Surgery. 148: 1282-7; discussion 1. PMID 21134562 DOI: 10.1016/J.Surg.2010.09.028  0.323
2010 Lee KE, Bar-Sagi D. Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells. Cancer Cell. 18: 448-58. PMID 21075310 DOI: 10.1016/J.Ccr.2010.10.020  0.357
2010 Xu L, Lubkov V, Taylor LJ, Bar-Sagi D. Feedback regulation of Ras signaling by Rabex-5-mediated ubiquitination. Current Biology : Cb. 20: 1372-7. PMID 20655225 DOI: 10.1016/J.Cub.2010.06.051  0.809
2010 Miaczynska M, Bar-Sagi D. Signaling endosomes: seeing is believing. Current Opinion in Cell Biology. 22: 535-40. PMID 20538448 DOI: 10.1016/J.Ceb.2010.05.007  0.326
2010 Yadav KK, Bar-Sagi D. Allosteric gating of Son of sevenless activity by the histone domain. Proceedings of the National Academy of Sciences of the United States of America. 107: 3436-40. PMID 20133694 DOI: 10.1073/Pnas.0914315107  0.642
2010 Gureasko J, Kuchment O, Makino DL, Sondermann H, Bar-Sagi D, Kuriyan J. Role of the histone domain in the autoinhibition and activation of the Ras activator Son of Sevenless Proceedings of the National Academy of Sciences of the United States of America. 107: 3430-3435. PMID 20133692 DOI: 10.1073/Pnas.0913915107  0.596
2010 Connolly MK, Mallen-St Clair J, Bedrosian AS, Malhotra A, Vera V, Ibrahim J, Henning J, Pachter HL, Bar-Sagi D, Frey AB, Miller G. Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. Journal of Leukocyte Biology. 87: 713-25. PMID 20042467 DOI: 10.1189/Jlb.0909607  0.329
2009 Ford B, Boykevisch S, Zhao C, Kunzelmann S, Bar-Sagi D, Herrmann C, Nassar N. Characterization of a Ras mutant with identical GDP- and GTP-bound structures . Biochemistry. 48: 11449-57. PMID 19883123 DOI: 10.1021/Bi901479B  0.416
2009 Fehrenbacher N, Bar-Sagi D, Philips M. Ras/MAPK signaling from endomembranes. Molecular Oncology. 3: 297-307. PMID 19615955 DOI: 10.1016/J.Molonc.2009.06.004  0.447
2009 Frank MJ, Dawson DW, Bensinger SJ, Hong JS, Knosp WM, Xu L, Balatoni CE, Allen EL, Shen RR, Bar-Sagi D, Martin GR, Teitell MA. Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas. Blood. 113: 2478-87. PMID 19147787 DOI: 10.1182/Blood-2008-05-156943  0.339
2008 Qi J, Nakayama K, Gaitonde S, Goydos JS, Krajewski S, Eroshkin A, Bar-Sagi D, Bowtell D, Ronai Z. The ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and -independent pathways. Proceedings of the National Academy of Sciences of the United States of America. 105: 16713-8. PMID 18946040 DOI: 10.1073/Pnas.0804063105  0.369
2008 Garcia A, Zheng Y, Zhao C, Toschi A, Fan J, Shraibman N, Brown HA, Bar-Sagi D, Foster DA, Arbiser JL. Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4267-74. PMID 18594009 DOI: 10.1158/1078-0432.Ccr-08-0102  0.446
2008 Gureasko J, Galush WJ, Boykevisch S, Sondermann H, Bar-Sagi D, Groves JT, Kuriyan J. Membrane-dependent signal integration by the Ras activator Son of sevenless. Nature Structural & Molecular Biology. 15: 452-61. PMID 18454158 DOI: 10.1038/Nsmb.1418  0.611
2008 Terrillon S, Bar-Sagi D. Biochemical and biophysical analyses of Ras modification by ubiquitin. Methods in Enzymology. 438: 259-76. PMID 18413254 DOI: 10.1016/S0076-6879(07)38018-X  0.365
2008 Gureasko J, Galush WJ, Boykevisch S, Sondermann H, Bar-Sagi D, Groves JT, Kuriyan J. Erratum: Membrane-dependent signal integration by the Ras activator Son of sevenless Nature Structural & Molecular Biology. 15: 651-651. DOI: 10.1038/nsmb0608-651a  0.557
2007 Yeh BJ, Rutigliano RJ, Deb A, Bar-Sagi D, Lim WA. Rewiring cellular morphology pathways with synthetic guanine nucleotide exchange factors. Nature. 447: 596-600. PMID 17515921 DOI: 10.1038/Nature05851  0.353
2007 Zhao C, Du G, Skowronek K, Frohman MA, Bar-Sagi D. Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nature Cell Biology. 9: 706-12. PMID 17486115 DOI: 10.1038/Ncb1594  0.448
2007 Kim HJ, Taylor LJ, Bar-Sagi D. Spatial regulation of EGFR signaling by Sprouty2. Current Biology : Cb. 17: 455-61. PMID 17320394 DOI: 10.1016/J.Cub.2007.01.059  0.315
2007 Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, Pandit B, Oishi K, Martinelli S, Schackwitz W, Ustaszewska A, Martin J, Bristow J, Carta C, Lepri F, ... ... Bar-Sagi D, et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nature Genetics. 39: 75-9. PMID 17143282 DOI: 10.1038/Ng1939  0.627
2007 Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, Pandit B, Oishi K, Martinelli S, Schackwitz W, Ustaszewska A, Martin J, Bristow J, Carta C, Lepri F, ... ... Bar-Sagi D, et al. Erratum: Corrigendum: Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome Nature Genetics. 39: 276-276. DOI: 10.1038/Ng0207-276A  0.531
2006 Jura N, Bar-Sagi D. Mapping cellular routes of Ras: a ubiquitin trail. Cell Cycle (Georgetown, Tex.). 5: 2744-7. PMID 17172849 DOI: 10.4161/Cc.5.23.3532  0.723
2006 Archer H, Jura N, Keller J, Jacobson M, Bar-Sagi D. A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology. 131: 1844-55. PMID 17087933 DOI: 10.1053/J.Gastro.2006.09.049  0.575
2006 Boykevisch S, Zhao C, Sondermann H, Philippidou P, Halegoua S, Kuriyan J, Bar-Sagi D. Regulation of Ras Signaling Dynamics by Sos-Mediated Positive Feedback Current Biology. 16: 2173-2179. PMID 17084704 DOI: 10.1016/J.Cub.2006.09.033  0.647
2006 Freedman TS, Sondermann H, Friedland GD, Kortemme T, Bar-Sagi D, Marqusee S, Kuriyan J. A Ras-induced conformational switch in the Ras activator Son of sevenless. Proceedings of the National Academy of Sciences of the United States of America. 103: 16692-7. PMID 17075039 DOI: 10.1073/Pnas.0608127103  0.625
2006 Jura N, Scotto-Lavino E, Sobczyk A, Bar-Sagi D. Differential modification of Ras proteins by ubiquitination. Molecular Cell. 21: 679-87. PMID 16507365 DOI: 10.1016/J.Molcel.2006.02.011  0.71
2005 Sondermann H, Zhao C, Bar-Sagi D. Analysis of Ras:RasGEF interactions by phage display and static multi-angle light scattering. Methods (San Diego, Calif.). 37: 197-202. PMID 16288886 DOI: 10.1016/J.Ymeth.2005.05.016  0.357
2005 Sondermann H, Nagar B, Bar-Sagi D, Kuriyan J. Computational docking and solution x-ray scattering predict a membrane-interacting role for the histone domain of the Ras activator son of sevenless Proceedings of the National Academy of Sciences of the United States of America. 102: 16632-16637. PMID 16267129 DOI: 10.1073/Pnas.0508315102  0.561
2005 Sparmann A, Bar-Sagi D. Ras oncogene and inflammation: partners in crime. Cell Cycle (Georgetown, Tex.). 4: 735-6. PMID 15908805 DOI: 10.4161/Cc.4.6.1714  0.502
2005 Ford B, Skowronek K, Boykevisch S, Bar-Sagi D, Nassar N. Structure of the G60A mutant of Ras: implications for the dominant negative effect. The Journal of Biological Chemistry. 280: 25697-705. PMID 15878843 DOI: 10.1074/Jbc.M502240200  0.439
2005 Jura N, Archer H, Bar-Sagi D. Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between. Cell Research. 15: 72-7. PMID 15686632 DOI: 10.1038/Sj.Cr.7290269  0.604
2004 Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell. 6: 447-58. PMID 15542429 DOI: 10.1016/J.Ccr.2004.09.028  0.504
2004 Sondermann H, Soisson SM, Boykevisch S, Yang SS, Bar-Sagi D, Kuriyan J. Structural analysis of autoinhibition in the Ras activator son of sevenless Cell. 119: 393-405. PMID 15507210 DOI: 10.1016/J.Cell.2004.10.005  0.633
2004 Agbunag C, Bar-Sagi D. Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells. Cancer Research. 64: 5659-63. PMID 15313904 DOI: 10.1158/0008-5472.Can-04-0807  0.437
2004 Kim HJ, Bar-Sagi D. Modulation of signalling by Sprouty: a developing story. Nature Reviews. Molecular Cell Biology. 5: 441-50. PMID 15173823 DOI: 10.1038/Nrm1400  0.303
2003 Sondermann H, Soisson SM, Bar-Sagi D, Kuriyan J. Tandem Histone Folds in the Structure of the N-Terminal Segment of the Ras Activator Son of Sevenless Structure. 11: 1583-1593. PMID 14656442 DOI: 10.1016/J.Str.2003.10.015  0.53
2003 Kennedy NJ, Sluss HK, Jones SN, Bar-Sagi D, Flavell RA, Davis RJ. Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes & Development. 17: 629-37. PMID 12629045 DOI: 10.1101/Gad.1062903  0.443
2003 Margarit SM, Sondermann H, Hall BE, Nagar B, Hoelz A, Pirruccello M, Bar-Sagi D, Kuriyan J. Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS. Cell. 112: 685-95. PMID 12628188 DOI: 10.1016/S0092-8674(03)00149-1  0.638
2003 Nimnual AS, Taylor LJ, Bar-Sagi D. Redox-dependent downregulation of Rho by Rac. Nature Cell Biology. 5: 236-41. PMID 12598902 DOI: 10.1038/Ncb938  0.335
2003 Hall AB, Jura N, DaSilva J, Jang YJ, Gong D, Bar-Sagi D. hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl. Current Biology : Cb. 13: 308-14. PMID 12593796 DOI: 10.1016/S0960-9822(03)00086-1  0.626
2002 Hall BE, Bar-Sagi D, Nassar N. The structural basis for the transition from Ras-GTP to Ras-GDP. Proceedings of the National Academy of Sciences of the United States of America. 99: 12138-42. PMID 12213964 DOI: 10.1073/Pnas.192453199  0.45
2002 Nimnual A, Bar-Sagi D. The two hats of SOS. Science's Stke : Signal Transduction Knowledge Environment. 2002: pe36. PMID 12177507 DOI: 10.1126/Stke.2002.145.Pe36  0.407
2002 Archer H, Bar-Sagi D. Ras and Rac as activators of reactive oxygen species (ROS). Methods in Molecular Biology (Clifton, N.J.). 189: 67-73. PMID 12094595 DOI: 10.1385/1-59259-281-3:067  0.363
2002 Egan JE, Hall AB, Yatsula BA, Bar-Sagi D. The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins. Proceedings of the National Academy of Sciences of the United States of America. 99: 6041-6. PMID 11983899 DOI: 10.1073/Pnas.052090899  0.331
2002 Hall BE, Yang SS, Bar-Sagi D. Autoinhibition of Sos by intramolecular interactions. Frontiers in Bioscience : a Journal and Virtual Library. 7: d288-94. PMID 11779695 DOI: 10.2741/Hall  0.447
2001 Lu W, Gong D, Bar-Sagi D, Cole PA. Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling Molecular Cell. 8: 759-769. PMID 11684012 DOI: 10.1016/S1097-2765(01)00369-0  0.314
2001 Hall BE, Yang SS, Boriack-Sjodin PA, Kuriyan J, Bar-Sagi D. Structure-based mutagenesis reveals distinct functions for Ras switch 1 and switch 2 in Sos-catalyzed guanine nucleotide exchange. The Journal of Biological Chemistry. 276: 27629-37. PMID 11333268 DOI: 10.1074/Jbc.M101727200  0.627
2001 Walsh AB, Bar-Sagi D. Differential Activation of the Rac Pathway by Ha-Ras and K-Ras Journal of Biological Chemistry. 276: 15609-15615. PMID 11278702 DOI: 10.1074/Jbc.M010573200  0.465
2001 Bar-Sagi D. A ras by any other name Molecular and Cellular Biology. 21: 1441-1443. PMID 11238880 DOI: 10.1128/Mcb.21.5.1441-1443.2001  0.462
2000 Bar-Sagi D, Hall A. Ras and Rho GTPases: A family reunion Cell. 103: 227-238. PMID 11057896 DOI: 10.1016/S0092-8674(00)00115-X  0.484
2000 Taylor LJ, Walsh AB, Hearing P, Bar-Sagi D. Single cell assays for Rac activity Methods in Enzymology. 325: 327-334. PMID 11036615 DOI: 10.1016/S0076-6879(00)25454-2  0.334
2000 Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ. Requirement of JNK for stress-induced activation of the cytochrome c- mediated death pathway Science. 288: 870-874. PMID 10797012 DOI: 10.1126/Science.288.5467.870  0.309
1999 Kumar CC, Ohashi K, Nagata K, Walsh A, Bar-Sagi D, Mizuno K. SCH 51334, an inhibitor of RAS/RAC-mediated cell morphology pathway Annals of the New York Academy of Sciences. 886: 122-131. PMID 10667210 DOI: 10.1111/J.1749-6632.1999.Tb09407.X  0.493
1999 Joneson T, Bar-Sagi D. Suppression of Ras-induced apoptosis by the Rac GTPpase Molecular and Cellular Biology. 19: 5892-5901. PMID 10454536 DOI: 10.1128/Mcb.19.9.5892  0.476
1998 Soisson SM, Nimnual AS, Uy M, Bar-Sagi D, Kuriyan J. Crystal structure of the Dbl and pleckstrin homology domains from the human Son of sevenless protein. Cell. 95: 259-68. PMID 9790532 DOI: 10.1016/S0092-8674(00)81756-0  0.504
1998 Boriack-Sjodin PA, Margarit SM, Bar-Sagi D, Kuriyan J. The structural basis of the activation of Ras by Sos. Nature. 394: 337-43. PMID 9690470 DOI: 10.1038/28548  0.618
1998 Joneson T, Bar-Sagi D. A Rac1 effector site controlling mitogenesis through superoxide production Journal of Biological Chemistry. 273: 17991-17994. PMID 9660749 DOI: 10.1074/Jbc.273.29.17991  0.36
1998 Joneson T, Fulton JA, Volle DJ, Chaika OV, Bar-Sagi D, Lewis RE. Kinase suppressor of Ras inhibits the activation of extracellular ligand-regulated (ERK) mitogen-activated protein (MAP) kinase by growth factors, activated Ras, and Ras effectors. The Journal of Biological Chemistry. 273: 7743-8. PMID 9516483 DOI: 10.1074/Jbc.273.13.7743  0.458
1998 Corbalan-Garcia S, Margarit SM, Galron D, Yang SS, Bar-Sagi D. Regulation of Sos activity by intramolecular interactions. Molecular and Cellular Biology. 18: 880-6. PMID 9447984 DOI: 10.1128/Mcb.18.2.880  0.381
1998 Nimnual AS, Yatsula BA, Bar-Sagi D. Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos Science. 279: 560-563. PMID 9438849 DOI: 10.1126/Science.279.5350.560  0.454
1997 Walsh AB, Dhanasekaran M, Bar-Sagi D, Kumar CC. SCH 51344-induced reversal of RAS-transformation is accompanied by the specific inhibition of the RAS and RAC-dependent cell morphology pathway. Oncogene. 15: 2553-60. PMID 9399643 DOI: 10.1038/Sj.Onc.1201424  0.482
1997 Colley WC, Sung TC, Roll R, Jenco J, Hammondt SM, Altshuller Y, Bar-Sagi D, Morris AJ, Frohman MA. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization Current Biology. 7: 191-201. PMID 9395408 DOI: 10.1016/S0960-9822(97)70090-3  0.356
1997 Joneson T, Bar-Sagi D. Ras effectors and their role in mitogenesis and oncogenesis Journal of Molecular Medicine. 75: 587-593. PMID 9297626 DOI: 10.1007/S001090050143  0.478
1997 Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I, Schlessinger J. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell. 89: 693-702. PMID 9182757 DOI: 10.1016/S0092-8674(00)80252-4  0.406
1997 Joneson T, Bar-Sagi D. Small gtpase cascades and growth control Faseb Journal. 11.  0.388
1996 Joneson T, McDonough M, Bar-Sagi D, Van Aelst L. RAC regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase. Science (New York, N.Y.). 274: 1374-6. PMID 8910277 DOI: 10.1126/Science.274.5291.1374  0.355
1996 Corbalan-Garcia S, Yang SS, Degenhardt KR, Bar-Sagi D. Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2 Molecular and Cellular Biology. 16: 5674-5682. PMID 8816480 DOI: 10.1128/Mcb.16.10.5674  0.305
1996 Van Aelst L, Joneson T, Bar-Sagi D. Identification of a novel Rac1-interacting protein involved in membrane ruffling. The Embo Journal. 15: 3778-86. PMID 8670882 DOI: 10.1002/J.1460-2075.1996.Tb00751.X  0.365
1996 Joneson T, White MA, Wigler MH, Bar-Sagi D. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science (New York, N.Y.). 271: 810-2. PMID 8628998 DOI: 10.1126/Science.271.5250.810  0.421
1996 Macara IG, Lounsbury KM, Richards SA, Mckiernan C, Bar-Sagi D. The Ras superfamily of GTPases Faseb Journal. 10: 625-630. PMID 8621061 DOI: 10.1096/fasebj.10.5.8621061  0.332
1995 Serrano M, Gómez-Lahoz E, DePinho RA, Beach D, Bar-Sagi D. Inhibition of ras-induced proliferation and cellular transformation by p16INK4 Science. 267: 249-252. PMID 7809631 DOI: 10.1126/Science.7809631  0.449
1995 Yang SS, Van Aelst L, Bar-Sagi D. Differential interactions of human Sos1 and Sos2 with Grb2. The Journal of Biological Chemistry. 270: 18212-5. PMID 7629138 DOI: 10.1074/Jbc.270.31.18212  0.386
1994 Boyer MJ, Gutmann DH, Collins FS, Bar-Sagi D. Crosslinking of the surface immunoglobulin receptor in B lymphocytes induces a redistribution of neurofibromin but not p120-GAP Oncogene. 9: 349-357. PMID 8290249  0.327
1994 Sun H, Tonks NK, Bar-Sagi D. Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1 Science. 266: 285-288. PMID 7939666 DOI: 10.1126/Science.7939666  0.382
1994 Schlessinger J, Bar-Sagi D. Activation of Ras and other signaling pathways by receptor tyrosine kinases. Cold Spring Harbor Symposia On Quantitative Biology. 59: 173-9. PMID 7587067 DOI: 10.1101/Sqb.1994.059.01.021  0.404
1994 Bar-Sagi D. The Sos (Son of sevenless) protein Trends in Endocrinology and Metabolism. 5: 165-169. DOI: 10.1016/1043-2760(94)90014-0  0.435
1993 Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessinger J, Wigler MH, Bar-Sagi D. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science (New York, N.Y.). 260: 1338-43. PMID 8493579 DOI: 10.1126/Science.8493579  0.447
1993 Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Bar-Sagi D, Margolis B, Schlessinger J. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature. 363: 85-8. PMID 8479541 DOI: 10.1038/363085A0  0.43
1993 Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J, Bar-Sagi D. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature. 363: 88-92. PMID 8386805 DOI: 10.1038/363088A0  0.449
1993 Simon M, Dodson G, Rubin G, Olivier J, Egan S, Giddings B, Brooks M, Buday L, Sizeland A, Weinberg R, Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D, ... ... Bar-Sagi D, et al. Tyrosine kinases to Ras Trends in Cell Biology. 3: 228. DOI: 10.1016/0962-8924(93)90117-J  0.4
1992 Bar-Sagi D. Mechanisms of signal transduction by Ras Seminars in Cell Biology. 3: 93-98. PMID 1611045 DOI: 10.1016/S1043-4682(10)80018-2  0.474
1992 Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 70: 431-42. PMID 1322798 DOI: 10.1016/0092-8674(92)90167-B  0.436
1991 Graziadei L, Burfeind P, Bar-Sagi D. Introduction of unlabeled proteins into living cells by electroporation and isolation of viable protein-loaded cells using dextran-fluorescein isothiocyanate as a marker for protein uptake Analytical Biochemistry. 194: 198-203. PMID 1714252 DOI: 10.1016/0003-2697(91)90168-S  0.306
1990 Cockcroft S, Bar-Sagi D. Effects of H-ras proteins on the activity of polyphosphoinositide phospholipase C in HL60 membranes Cellular Signalling. 2: 227-234. PMID 2169290 DOI: 10.1016/0898-6568(90)90050-K  0.305
1990 Graziadei L, Riabowol K, Bar-Sagi D. Co-capping of ras proteins with surface immunoglobulins in B lymphocytes. Nature. 347: 396-400. PMID 2120590 DOI: 10.1038/347396A0  0.383
1989 Bar-Sagi D. Ras proteins: Biological effects and biochemical targets (Review) Anticancer Research. 9: 1427-1438. PMID 2686537  0.386
1988 Bar-Sagi D, Suhan JP, McCormick F, Feramisco JR. Localization of phospholipase A2 in normal and ras-transformed cells Journal of Cell Biology. 106: 1649-1658. PMID 3286660 DOI: 10.1083/Jcb.106.5.1649  0.435
1988 Bar-Sagi D, Gomperts BD. Stimulation of exocytotic degranulation by microinjection of the ras oncogene protein into rat mast cells Oncogene. 3: 463-469. PMID 3078954  0.37
1987 Bar-Sagi D, McCormick F, Milley RJ, Feramisco JR. Inhibition of cell surface ruffling and fluid-phase pinocytosis by microinjection of anti-ras antibodies into living cells Journal of Cellular Physiology. 133: 69-73. PMID 3316255 DOI: 10.1002/Jcp.1041330414  0.452
1987 Bar-Sagi D, Fernandez A, Feramisco JR. Regulation of membrane turnover by ras proteins Bioscience Reports. 7: 427-434. PMID 3315033 DOI: 10.1007/Bf01362505  0.456
1986 Bar-Sagi D, Feramisco JR. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins Science. 233: 1061-1068. PMID 3090687 DOI: 10.1126/Science.3090687  0.454
1985 Bar-Sagi D, Feramisco JR. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation Cell. 42: 841-848. PMID 2996779 DOI: 10.1016/0092-8674(85)90280-6  0.442
Show low-probability matches.